Fasinumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AztecWarrior28 (talk | contribs) at 23:45, 12 May 2012 (create mab page). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Fasinumab
Monoclonal antibody
Type?
SourceHuman
TargetHNGF
Clinical data
ATC code
  • none
Identifiers
CAS Number
Chemical and physical data
FormulaC6406H9896N1700O2026S46
Molar mass144.6 kDa g·mol−1

Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1]

This drug was developed by Regeneron Pharmaceuticals.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fasinumab&oldid=492282062"